NYSE:RCUS

Arcus Biosciences Stock Forecast

etoro logo Buy RCUS
*Your capital is at risk
$28.42
-1.31 (-4.41%)
At Close: Jul 24, 2026
AI Analysis AI Analysis of RCUS AI-Powered Market Insights
Stock Analysis PRO New!
Risk Assessment PRO New!
Trading Strategy PRO New!
Add RCUS to Watchlist?
Some Reasons Why To Add RCUS:
  • +177.8% price growth over the last year
  • High gross margin of 97.0%
  • Bullish trend confirmed on both short and long timeframes
PDF

Arcus Biosciences Inc. stock upgraded from Hold/Accumulate to Buy Candidate after Friday trading session
(Updated on Jul 24, 2026)

Buy or Hold candidate since Jul 17, 2026 Gain 3.84%

The Arcus Biosciences Inc. stock price fell by -4.41% on the last day (Friday, 24th Jul 2026) from $29.73 to $28.42. During the last trading day the stock fluctuated 6.49% from a day low at $28.33 to a day high of $30.17. The price has been going up and down for this period, and there has been a -1.73% loss for the last 2 weeks. Volume fell on the last day along with the stock, which is actually a good sign as volume should follow the stock. On the last day, the trading volume fell by -343 thousand shares and in total, 874 thousand shares were bought and sold for approximately $24.84 million.

The stock lies in the middle of a very wide and strong rising trend in the short term and a further rise within the trend is signaled. Given the current short-term trend, the stock is expected to rise 21.82% during the next 3 months and, with a 90% probability hold a price between $30.47 and $39.97 at the end of this 3-month period.

RCUS Signals & Forecast

The Arcus Biosciences Inc. stock holds a sell signal from the short-term Moving Average; at the same time, however, there is a buy signal from the long-term average. Since the short-term average is above the long-term average there is a general buy signal in the stock giving a positive forecast for the stock. On further gains, the stock will meet resistance from the short-term Moving Average at approximately $28.54. On a fall, the stock will find some support from the long-term average at approximately $27.44. A break-up through the short-term average will send a buy signal, whereas a breakdown through the long-term average will send a sell signal. Some negative signals were issued as well, and these may have some influence on the near short-term development. A sell signal was issued from a pivot top point on Monday, June 29, 2026, and so far it has fallen -8.56%. Further fall is indicated until a new bottom pivot has been found. Furthermore, there is currently a sell signal from the 3 month Moving Average Convergence Divergence (MACD). Volume fell together with the price during the last trading day and this reduces the overall risk as volume should follow the price movements.

Support, Risk & Stop-loss for Arcus Biosciences Inc. stock

Arcus Biosciences Inc. finds support from accumulated volume at $28.18 and this level may hold a buying opportunity as an upwards reaction can be expected when the support is being tested.

This stock has average movements during the day and with good trading volume, the risk is considered to be medium. During the last day, the stock moved $1.84 between high and low, or 6.49%. For the last week, the stock has had daily average volatility of 5.18%.

Our recommended stop-loss: $27.14 (-4.50%) (This stock has medium daily movements and this gives medium risk. There is a sell signal from a pivot top found 18 days ago.)

Trading Expectations (RCUS) For The Upcoming Trading Day Of Monday 27th

For the upcoming trading day on Monday, 27th we expect Arcus Biosciences Inc. to open at $28.97, and during the day (based on 14 day Average True Range), to move between $27.65 and $29.19, which gives a possible trading interval of +/-$1.54 (+/-5.57%) up or down from last closing price. If Arcus Biosciences Inc. takes out the full calculated possible swing range there will be an estimated 5.57% move between the lowest and the highest trading price during the day.

Since the stock is closer to the support from accumulated volume at $28.18 (0.84%) than the resistance at $28.92 (1.76%), our systems sees the trading risk/reward intra-day as attractive and believe profit can be made before the stock reaches first resistance..

Is Arcus Biosciences Inc. stock A Buy?

Several short-term signals, along with a general good trend, are positive and we conclude that the current level may hold a buying opportunity as there is a fair chance for Arcus Biosciences Inc. stock to perform well in the short-term. We have upgraded our analysis conclusion for this stock since the last evaluation from a Hold to a Buy candidate.

Current score: 2.397 Buy Candidate Upgraded

Predicted Fair Opening Price

Predicted fair opening price on July 27, 2026 - $28.97 ( 1.95%).

Want to trade but not sure how? Our step-by-step guide can help.
Skip the guide? Open account with our trusted broker* eToro
*Your capital is at risk

RCUS Performance

Trading levels for RCUS

StockInvest.us
Full Access. No Commitment. 7 Days Free!
Long & Short-Term Golden Star Lists
AI Stock Analysis*
Top 10 Candidates on Every List
Premium Lists
Ad-FREE Browsing
Advanced Stock Screener

Fibonacci Support & Resistance Levels

Level Price
R3 30.81 8.42%
R2 30.11 5.95%
R1 29.68 4.42%
Price 28.42
S1 28.27 -0.526%
S2 27.84 -2.05%
S3 27.13 -4.53%

Accumulated Volume Support & Resistance Levels

Level Price
R3 31.00 9.08%
R2 30.25 6.44%
R1 28.92 1.76%
Price 28.42
S1 28.18 -0.84%
S2 27.23 -4.19%
S3 25.34 -10.84%

FAQ

What is the symbol for Arcus Biosciences Inc. Stock and on which exchange is it traded?
The symbol for Arcus Biosciences Inc. is RCUS and it is traded on the NYSE (New York Stock Exchange).

Should I buy or sell Arcus Biosciences Inc. Stock?
Several short-term signals, along with a general good trend, are positive and we conclude that the current level may hold a buying opportunity as there is a fair chance for Arcus Biosciences Inc. stock to perform well in the short-term. We have upgraded our analysis conclusion for this stock since the last evaluation from a Hold to a Buy candidate.

How to buy Arcus Biosciences Inc. Stock?
Arcus Biosciences Inc. Stock can be purchased through just about any brokerage firm, including online brokerage services.
Click here for our free guide on how to buy Arcus Biosciences Inc. Stock.

What's the current price of Arcus Biosciences Inc. Stock?
As of the end of day on the Jul 24, 2026, the price of an Arcus Biosciences Inc. (RCUS) share was $28.42.

What is the 52-week high and low for Arcus Biosciences Inc. Stock?
The 52-week high for Arcus Biosciences Inc. Stock is $31.69 and the 52-week low is $8.85.

What is the market capitalization of Arcus Biosciences Inc. Stock?
As of the Jul 24, 2026, the market capitalization of Arcus Biosciences Inc. is 2.861B.

When is the next earnings date for Arcus Biosciences Inc.?
The upcoming earnings date for Arcus Biosciences Inc. is Aug 05, 2026.
Click to get the best stock tips daily for free!
ABOUT ARCUS BIOSCIENCES INC.
Arcus Biosciences
Arcus Biosciences, Inc., a clinical-stage biopharmaceutical company, develops and commercializes cancer therapies in the United States. Its product pipeline includes, Etrumadenant, a dual A2a/A2b adenosine receptor antagonist, which is in a Phase 1b/2 clinical trial; and Zimberelimab, an anti-PD-1 antibody that is in Phase 1b clinical trial for monotherapy. The company also develops Domvanalimab, an anti-TIGIT monoclonal antibody, which is in Pha...
GOLDEN STAR
Ticker Change Signal Date
KMT
$34.39
2.44% Jul 21
DHT
$17.31
6.59% Jul 13
NMRK
$15.02
2.46% Jun 24
JLL
$299.78
8.56% Jun 24
ROP
$331.60
10.78% Jun 24

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE